Your search returned 125 studies. (Get alerts for new studies):
- Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer
Conditions: Prostate Cancer - Adenocarcinoma
4 Locations available
- Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duoden
Conditions: Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Liver Cancer - Pancreatic Cancer - Periampullary Adenocarcinoma - Small Intestine Cancer
2 Locations available
- Intensity-Modulated External Beam Radiation Therapy in Treating Patients With Prostate Cancer
Conditions: Adenocarcinoma of the Prostate - Stage I Prostate Cancer - Stage II Prostate Cancer - Stage III Prostate Cancer - Stage IV Prostate Cancer
2 Locations available
- Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Canc
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer
188 Locations available
- Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer - Adenocarcinoma of the Prostate - Hormone-resistant Prostate Cancer - Recurrent Prostate Cancer - Stage IV Prostate Cancer
1 Location available
- GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Conditions: Adenocarcinoma of the Pancreas - Advanced Solid Tumors - Cancer - Cancer of Pancreas - Cancer of the Pancreas - Metastases - Metastatic Cancer - Metastatic Pancreatic Cancer - Pancreas Cancer - Pancreatic Cancer - Bone Metastases - Endocrine Cancer - Onco
20 Locations available
- MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer - Gastric Cancer
105 Locations available
- Midostaurin (PKC412) for Locally Advanced Rectal Cancer
Conditions: Adenocarcinoma of the Rectum
1 Location available
- Laparoscopy-Assisted Transanal Endoscopy Rectosigmoid Resection for Rectal Cancer
Conditions: Adenocarcinoma of the Rectum
2 Locations available
- Radiation Therapy, Tadalafil, Sargramostim, Gemcitabine, and Telomerase Vaccine (GV1001) in Patients With Pancreatic Cancer
Conditions: Locally Advanced Pancreatic Adenocarcinoma
1 Location available
- Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix
Conditions: Cervical Squamous Cell Carcinoma - Adenosquamous Carcinoma - Adenocarcinoma - Locally Advanced Malignant Neoplasm - Cervical Cancer
1 Location available
- Cancer Vaccines CRS-207 and GVAX Pancreas for Metastatic Pancreatic Adenocarcinoma
Conditions: Pancreatic Cancer
7 Locations available
- Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
Conditions: Colorectal Cancer
30 Locations available
- Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors or Advanced Pancreatic Ca
Conditions: Adenocarcinoma of the Pancreas - Stage III Pancreatic Cancer - Stage IV Pancreatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- AMG 172 First in Human Study in Patients With Kidney Cancer
Conditions: Renal Cell Adenocarcinoma - Clear Cell Renal Carcinoma - Clear Cell Renal Cell Carcinoma - Renal Cell Carcinoma
3 Locations available
- Degarelix Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate Cancer
Conditions: Prostate Cancer - Prostatic Adenocarcinoma
1 Location available
- Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma
Conditions: Esophageal Adenocarcinoma - Gastric Adenocarcinoma
2 Locations available
- PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung
Conditions: Carcinoma, Non-small Cell
6 Locations available
- A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Conditions: Stomach Neoplasms - Esophageal Neoplasms
3 Locations available
- Ixabepilone to Treat Cervical Cancer
Conditions: Cervical Carcinoma - Cervical Adenocarcinoma - Cervical Adenosquamous Carcinoma - Cervical Carcinoma, Non-SquamousType
1 Location available
- Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastro
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer - Gastric Cancer
208 Locations available
- Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetax
Conditions: Non-small Cell Lung Cancer
4 Locations available
- A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma
Conditions: Gastric Cancer
11 Locations available
- Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers
Conditions: Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Liver Cancer - Periampullary Adenocarcinoma
7 Locations available
- Mild Hypofractionation With Proton Therapy or Intensity Modulated Radiation Therapy (IMRT) for Intermediate-Risk Prostate Cancer
Conditions: Prostate Adenocarcinoma
1 Location available
- FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
Conditions: Pancreatic Cancer - Adenocarcinoma - Pancreatic Neoplasms
1 Location available
- -02341066 and PF-00299804 for Advanced Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small Cell Lung - Adenocarcinoma - Carcinoma, Squamous Cell - Carcinoma, Large Cell
1 Location available
- A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Conditions: Pancreatic Cancer
22 Locations available
- Feasibility of Obtaining and Characterizing Circulating Tumorigenic Cells in Patients With Pancreatic Adenocarcinoma
Conditions: Pancreatic Adenocarcinoma
1 Location available
- Hypo-fractionated Proton Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Adenocarcinoma of the Prostate
Conditions: Prostate Cancer
1 Location available
- Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery
Conditions: Acinar Cell Adenocarcinoma of the Pancreas - Duct Cell Adenocarcinoma of the Pancreas - Recurrent Pancreatic Cancer - Stage IV Pancreatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma
Conditions: Esophageal Neoplasms - Stomach Neoplasms - Neoplasm Metastasis
2 Locations available
- Endoscopic Mucosal Resection (EMR) in Barrett's Esophagus
Conditions: Barrett's Esophagus - Early Esophageal Adenocarcinoma
1 Location available
- The Effect of Ablation Therapy on Barrett's Esophagus
Conditions: Barrett's Esophagus - Early Esophageal Adenocarcinoma
1 Location available
- Cinacalcet Hydrochloride in Treating Men With Recurrent Prostate Cancer
Conditions: Adenocarcinoma of the Prostate - Recurrent Prostate Cancer
1 Location available
- Genistein in Treating Patients With Prostate Cancer
Conditions: Adenocarcinoma of Prostate - Prostate Cancer Recurrent - Stage I Prostate Carcinoma - Stage II Prostate Carcinoma - Stage III Prostate Carcinoma
1 Location available
- Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer
134 Locations available
- Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery
Conditions: Mucinous Adenocarcinoma of the Rectum - Stage IIA Rectal Cancer - Stage IIB Rectal Cancer - Stage IIC Rectal Cancer - Stage IIIB Rectal Cancer - Stage IIIC Rectal Cancer
1 Location available
- A Study to Evaluate the Safety and Tolerability of MEDI-565 in Adults With Gastrointestinal Adenocarcinomas
Conditions: Gastrointestinal Adenocarcinomas
3 Locations available
- Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma
Conditions: Pancreatic Cancer
1 Location available
- Prospective Randomized Trial Comparing Robotic Versus Open Radical Prostatectomy
Conditions: Prostatic Neoplasms - Adenocarcinoma
1 Location available
- Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGF
Conditions: Colorectal Cancer - Colorectal Adenocarcinoma
1 Location available
- A Phase I/II/Pharmacodynamic Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane to Inhibit Autophagy in Pancreatic Cancer
Conditions: Advanced Adenocarcinoma - Metastatic Adenocarcinoma
1 Location available
- Safety Study of Modified Vaccinia Virus to Cancer
Conditions: Melanoma - Breast Cancer - Head and Neck Squamous Cell Cancer - Liver Cancer - Colorectal Cancer - Pancreatic Adenocarcinoma
1 Location available
- The Pancreatic Adenocarcinoma Gene Environment Risk Study - A Study of Patients at Risk or Having Pancreatic Disease
Conditions: Pancreatic Cancer
3 Locations available
- A Study of REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma
Conditions: Metastatic Pancreatic Adenocarcinoma
2 Locations available
- Stereotactic Radiation Therapy, Nelfinavir Mesylate, Gemcitabine Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Locally
Conditions: Adenocarcinoma of the Pancreas - Pancreatic Cancer - Stage III Pancreatic Cancer
1 Location available
- A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotherapy in Locally Advanced Adenocarcinoma of the Rectum
Conditions: Non-Metastatic Adenocarcinoma of the Rectum
1 Location available
- Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma
Conditions: Pancreatic Cancer
3 Locations available
- Hsp90 Inhibitor STA-9090 as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
Conditions: Adenocarcinoma of the Pancreas - Recurrent Pancreatic Cancer - Stage IV Pancreatic Cancer
1 Location available
- PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer
12 Locations available
- Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer
Conditions: Mucinous Adenocarcinoma of the Colon - Mucinous Adenocarcinoma of the Rectum - Signet Ring Adenocarcinoma of the Colon - Signet Ring Adenocarcinoma of the Rectum - Stage I Colon Cancer - Stage I Rectal Cancer
1 Location available
- The Prostate Immobilization Device Study
Conditions: Adenocarcinoma of the Prostate
1 Location available
- Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma
Conditions: Pancreas, Adenocarcinoma
2 Locations available
- Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
Conditions: Prostatic Neoplasm - Prostate Cancer - Prostatic Adenocarcinoma
14 Locations available
- Gemcitabine in Combination With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma
Conditions: Resectable Pancreatic Adenocarcinoma
1 Location available
- A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.
Conditions: Metastatic Pancreatic Adenocarcinoma - Pancreatic Cancer - Metastatic Pancreatic Cancer
1 Location available
- Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
Conditions: Gastroesophageal Junction Adenocarcinoma - Gastric Cancer
15 Locations available
- Lung Cancer Mutation Consortium Protocol
Conditions: Stage IIIB/IV Adenocarcinoma
1 Location available
- A Phase 1 Study of MLN8237 in Patients With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regime
Conditions: Advanced Solid Tumors - Adenocarcinoma of the Prostate
1 Location available
- Study of Pre-surgery Gemcitabine + Hydroxychloroquine (GcHc) in Stage IIb or III Adenocarcinoma of the Pancreas
Conditions: Pancreatic Cancer
1 Location available
- Adjuvant Intraperitoneal Gemcitabine for Resectable Pancreatic Adenocarcinoma
Conditions: Pancreatic Adenocarcinoma
1 Location available
- FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer
Conditions: Rectal Cancer - Colon Cancer - Metastasis - Adenocarcinoma
1 Location available
- A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
Conditions: Adenocarcinoma of the Lung
54 Locations available
- Pancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic Adenocarcinoma
Conditions: Pancreatic Cancer
1 Location available
- Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery
Conditions: Acinar Cell Carcinoma of Pancreas - Duct Cell Adenocarcinoma of the Pancreas - Pancreatic Carcinoma Recurrent - Stage IA Pancreatic Cancer - Stage IB Pancreatic Cancer - Stage IIA Pancreatic Cancer - Stage IIB Pancreatic Cancer - Pancreatic Carcinoma Stag
17 Locations available
- Phenelzine Sulfate and Docetaxel for Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel
Conditions: Adenocarcinoma of the Prostate - Castrate Resistant Prostate Cancer - Recurrent Prostate Cancer
1 Location available
- Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
Conditions: Recurrent Colon Cancer - Recurrent Rectal Cancer - Stage IV Colon Cancer - Stage IV Rectal Cancer - Adenocarcinoma of the Colon - Adenocarcinoma of the Rectum - KRAS Protein, Human
1 Location available
- Study of Ruxolitinib in Pancreatic Cancer Patients
Conditions: Metastatic Pancreatic Adenocarcinoma
27 Locations available
- An Evaluation of Polymer Based Fiducials for Use in Imaging Patients Receiving Treatment for Prostate Cancer
Conditions: Prostate Adenocarcinoma
1 Location available
- Ipilimumab in Combination With Androgen Suppression Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Adenocarcinoma of the Prostate - Hormone-resistant Prostate Cancer - Recurrent Prostate Cancer - Stage IV Prostate Cancer
1 Location available
- Combination Chemotherapy, Intensity-Modulated Radiation Therapy, and Surgery in Treating Patients With Localized Pancreatic Cancer That Can Be Removed
Conditions: Adenocarcinoma of the Pancreas - Stage IA Pancreatic Cancer - Stage IB Pancreatic Cancer - Stage IIA Pancreatic Cancer - Stage IIB Pancreatic Cancer
1 Location available
- Permission to Collect Blood Over Time for Research
Conditions: Pancreatic Cancer - Gastrointestinal Neoplasms - Colon Rectal Cancer Adenocarcinoma - Esophageal Cancer - Gall Bladder Cancer - Gastric (Stomach) Cancer - Gastrooesophageal Cancer - Gastrointestinal Stromal Tumor (GIST) - Hepatobiliary Neoplasm - Liver Ca
1 Location available
- Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma
Conditions: Gastric Cancer - Adenocarcinoma
26 Locations available
- Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma
Conditions: Biliary Cancer - Cholangiocarcinoma
1 Location available
- Abiraterone Acetate, Prednisone, and Leuprolide Acetate or Goserelin Before and During Radiation Therapy in Treating Patients With Localized or Locall
Conditions: Adenocarcinoma of the Prostate - Stage II Prostate Cancer - Stage III Prostate Cancer - Stage IV Prostate Cancer
2 Locations available
- PD 0332991 in Treating Patients With Refractory Solid Tumors
Conditions: Adult Solid Tumor - Adenocarcinoma of the Colon - Adenocarcinoma of the Rectum - Adult Central Nervous System Germ Cell Tumor - Adult Teratoma - Benign Teratoma - Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - Famili
1 Location available
- Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas
Conditions: Metastatic Pancreatic Cancer
2 Locations available
- Lenalidomide and Cyclophosphamide in Treating Patients With Previously Treated Hormone-Refractory Prostate Cancer
Conditions: Adenocarcinoma of the Prostate - Hormone-resistant Prostate Cancer - Recurrent Prostate Cancer
3 Locations available
- A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver
Conditions: Colorectal Neoplasms - Liver Neoplasms
3 Locations available
- Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung - Non-small Cell Lung Cancer
1 Location available
- A Phase III Trial of Hypofractionated External Beam Image-Guided Highly Targeted Radiotherapy: The HEIGHT Trial
Conditions: Prostate Cancer - Prostate Adenocarcinoma
1 Location available
- A Phase III Randomized Trial of MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial
Conditions: Prostate Cancer - Prostate Adenocarcinoma
1 Location available
- Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors
Conditions: Solid Tumour - Adenocarcinoma of the Colon - Adenocarcinoma of the Pancreas
3 Locations available
- Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Adenocarcinoma of the Prostate - Hormone-resistant Prostate Cancer - Recurrent Prostate Cancer - Stage IV Prostate Cancer
1 Location available
- Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Conditions: Carcinomas (Including Squamous Cell and Adenocarcinoma) - Neoplasms
1 Location available
- Identification of Key Blood Molecular Markers for Immunotherapy
Conditions: Squamous Cell Carcinoma - Adenocarcinoma - Neoplasms
1 Location available
- Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate
Conditions: Prostate Cancer
1 Location available
- Perioperative Treatment With Zoledronic Acid in Patients With Resectable Pancreas Cancer
Conditions: Adenocarcinoma
1 Location available
- Follow Up Protocol for Subjects Previously Enrolled in NCI Surgery Branch Studies
Conditions: Melanoma - Adenocarcinoma - Carcinoma NOS - Neuroendocrine Tumors
1 Location available
- Combination Chemotherapy With or Without GDC-0449 in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Gastric Cancer
17 Locations available
- MLN8237 in Adults With Nonhematological Malignancies, Followed by MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies
Conditions: Advanced Nonhematological Malignancies - Non-Small Cell Lung Cancer - Small Cell Lung Cancer - Metastatic Breast Cancer - Head and Neck Squamous Cell Carcinoma - Gastroesophageal Adenocarcinoma
3 Locations available
- Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy
Conditions: Adenocarcinoma of the Esophagus - Adenocarcinomas of the Gastroesophageal Junction - Recurrent Esophageal Cancer - Squamous Cell Carcinoma of the Esophagus - Stage IV Esophageal Cancer
1 Location available
- Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Macrobeads in the Treatment of Patients With Castration-Resistant Prostate Cancer Res
Conditions: Prostate Cancer
1 Location available
- CAPOX in KRAS Wild-Type Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater
Conditions: Gastrointestinal Cancer
1 Location available
- Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer
Conditions: Adenocarcinoma of the Esophagus - Diffuse Adenocarcinoma of the Stomach - Intestinal Adenocarcinoma of the Stomach - Mixed Adenocarcinoma of the Stomach - Stage IV Esophageal Cancer - Stage IV Gastric Cancer
2 Locations available
- Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
Conditions: Adenocarcinoma of the Prostate - Hormone-resistant Prostate Cancer - Recurrent Prostate Cancer - Stage IV Prostate Cancer
4 Locations available
- Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma
Conditions: Rectal Cancer Stage II - Rectal Cancer Stage III
1 Location available
- Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
Conditions: Metastatic Pancreatic Adenocarcinoma
18 Locations available
- Esophageal Protocol for Detection of Neoplasia in the Digestive Tract
Conditions: Barrett Esophagus - Esophageal Adenocarcinoma
1 Location available
- Lapatinib With Carboplatin and Paclitaxel in Esophagus and Gastroesophageal Junction (GEJ)
Conditions: Adenocarcinoma of the Esophagus - Adenocarcinoma of the Gastroesophageal Junction
1 Location available
- A Phase I Trial of MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate Cancer
Conditions: Prostate Cancer - Prostate Adenocarcinoma
1 Location available
- FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
Conditions: Pancreatic Neoplasms
1 Location available
- Combination Chemotherapy in Treating Patients With Advanced or Metastatic Esophageal Cancer, Gastric Cancer, or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer - Gastric Cancer
135 Locations available
- C11-Acetate PET/CT Imaging in Prostate Adenocarcinoma, Study of Impact in Initial Treatment and in Treatment Monitoring
Conditions: Prostate Cancer - Prostate Adenocarcinoma
1 Location available
- A Randomized Phase II Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.
Conditions: Patients Must Have Histologically or Cytologically Confirmed Non-squamous Cell, Non Small Cell Carcinoma of the Lung. - Patient Must Have Measurable Stage IV Disease (Includes M1a, M1b Stages or Recurrent Disease).
1 Location available
- Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
Conditions: Barrett's Esophagus - Gastroesophageal Reflux Disease - Esophageal Adenocarcinoma
1 Location available
- Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer
Conditions: Adenocarcinoma of the Ovary
3 Locations available
- Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Can
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer
21 Locations available
- Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing Observation
Conditions: Adenocarcinoma of the Prostate - Stage I Prostate Cancer - Stage II Prostate Cancer - Stage III Prostate Cancer - Stage IV Prostate Cancer
1 Location available
- Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone
Conditions: Adenocarcinoma - Her2+ - Advanced Metastatic Breast Cancer - Metastatic ErbB2 - Invasive Breast Cancer - Advanced Breast Cancer - Cancer - ErbB2+
19 Locations available
- Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer
Conditions: Pancreatic Cancer - Periampullary Adenocarcinoma
1 Location available
- Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Gastric Cancer
24 Locations available
- MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the Prostate
Conditions: Prostate Cancer - Adenocarcinoma of the Prostate - Stage I Prostate Cancer - Stage II Prostate Cancer - Stage III Prostate Cancer
1 Location available
- Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancer
Conditions: Prostate Cancer - Adenocarcinoma of the Prostate - Hormone-resistant Prostate Cancer - Stage IV Prostate Cancer
1 Location available
- Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Esophagus - Adenocarcinoma of the Gastroesophageal Junction - Diffuse Adenocarcinoma of the Stomach - Intestinal Adenocarcinoma of the Stomach - Mixed Adenocarcinoma of the Stomach - Recurrent Esophageal Cancer - Recurrent Gastric Ca
1 Location available
- Bevacizumab With Capecitabine and Oxaliplatin in Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater
Conditions: Gastrointestinal Cancers
1 Location available
- Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma
Conditions: Metastatic Pancreatic Adenocarcinoma
12 Locations available
- Panitumumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Advanced Esophageal or Gastroesophageal Junction
Conditions: Adenocarcinoma of the Esophagus - Adenocarcinoma of the Gastroesophageal Junction - Stage II Esophageal Cancer
1 Location available
- Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With
Conditions: Adenocarcinoma of the Lung - Adenosquamous Cell Lung Cancer - Large Cell Lung Cancer - Recurrent Non-small Cell Lung Cancer - Squamous Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Ce
1 Location available
- FOLFIRINOX in Patients With Inoperable Pancreatic Cancer
Conditions: Adenocarcinoma of Pancreas
1 Location available
- Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC)
Conditions: Esophageal Cancer - Adenocarcinoma
1 Location available
- Feasibility and Safety Study in Patients With Metastatic Pancreatic Adenocarcinoma
Conditions: Metastatic Pancreatic Cancer
1 Location available
- Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic Adenocarcinoma
Conditions: Pancreatic Cancer
1 Location available
- Pre-Operative, Single-Dose Ipilimumab and/or Cryoablation in Early Stage/Resectable Breast Cancer
Conditions: Breast Cancer - Invasive Adenocarcinoma of the Breast
1 Location available
|